Rona Therapeutics
PrivateLast Round
Series A
Extension
Jul 19, 2024
Total Funding Raised
$68M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Rona Therapeutics is a biotechnology company that develops an RNA therapeutics platform designed for RNA medicine discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rona Therapeutics Comparables
Compare Rona Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Argo Biopharma | 89% | |
| Visirna Therapeutics | 88% | |
| Sirius Therapeutics, Inc. | 86% |
Rona Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 19, 2024 | ||||
| Series A | Apr 7, 2022 |
Rona Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longriver Investment Partners | Series A Extension |
| BioTrack Capital | Series A Extension |
| 招银国际金融有限公司 | Series A |
| Lapam Capital | Series A, Series A Extension |
| Platanus Ventures | Series A |
| LongRiver Investments | Series A Extension |
| Lilly Asia Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors grew 117% MoM, reaching 3.6K.
- Jan 6, 2026
Monthly visitors increased 2227% MoM, reaching 7.5K.
Rona Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rona Therapeutics's valuation, stock price, and market status.
Is Rona Therapeutics a public or private company?
Rona Therapeutics is a private company.
What is the current stock price of Rona Therapeutics?
Rona Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Rona Therapeutics worth (valuation)?
Valuation information for Rona Therapeutics is not publicly available.
Can I buy Rona Therapeutics stock?
Rona Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rona Therapeutics's last funding round?
Rona Therapeutics's most recent funding round was Series A Extension on July 19, 2024.
Who are the main investors in Rona Therapeutics?
Key investors in Rona Therapeutics include LongRiver Investments.
Will Rona Therapeutics IPO soon?
No public IPO plans have been announced for Rona Therapeutics.
How can I track Rona Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rona Therapeutics's secondary market activity and sign up for updates.